SERES THERAPEUTICS
Seres Therapeutics is a clinical-stage biotherapeutic company that develops ecobiotic therapeutic products. They engaged in developing biological drugs which are referred to as ecobiotic microbiome therapeutics.
SERES THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2010-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.serestherapeutics.com
Total Employee:
251+
Status:
Active
Contact:
+1 617 945 9626
Email Addresses:
[email protected]
Total Funding:
402.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Nginx Sitelinks Search Box
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
NextCure
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Seres Therapeutics
CARB-X
CARB-X investment in Grant - Seres Therapeutics
Nestlรฉ Health Science
Nestlรฉ Health Science investment in Series D - Seres Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series C - Seres Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series B - Seres Therapeutics
Alexandria Venture
Alexandria Venture investment in Series B - Seres Therapeutics
Enso Ventures
Enso Ventures investment in Series B - Seres Therapeutics
Mayo Clinic
Mayo Clinic investment in Series B - Seres Therapeutics
Enso Ventures
Enso Ventures investment in Series A - Seres Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series A - Seres Therapeutics
Newest Events participated
Key Employee Changes
Date | New article |
---|---|
2022-02-08 | Seres Therapeutics Appoints Paula Cloghessy as Executive Vice President, Chief People Officer |
Official Site Inspections
http://www.serestherapeutics.com Semrush global rank: 1.94 M Semrush visits lastest month: 11.12 K
- Host name: 14.165.188.35.bc.googleusercontent.com
- IP address: 35.188.165.14
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York